NLS Pharmaceutics (NLSPW) Competitors $0.0045 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NLSPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying NLS Pharmaceutics stock or one of its competitors? The main competitors of NLS Pharmaceutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. NLS Pharmaceutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity NLS Pharmaceutics (NASDAQ:NLSPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, community ranking, media sentiment, institutional ownership and profitability. Does the MarketBeat Community believe in NLSPW or ATNFW? NLS Pharmaceutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNLS PharmaceuticsN/AN/A180 Life SciencesN/AN/A Is NLSPW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets NLS PharmaceuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor NLSPW or ATNFW? In the previous week, NLS Pharmaceutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for NLS Pharmaceutics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 beat NLS Pharmaceutics' score of -1.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment NLS Pharmaceutics Negative 180 Life Sciences Neutral Which has preferable valuation and earnings, NLSPW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNLS PharmaceuticsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryNLS Pharmaceutics and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Get NLS Pharmaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NLSPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NLSPW vs. The Competition Export to ExcelMetricNLS PharmaceuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$119.72M$5.30B$7.35BDividend YieldN/A3.75%5.12%4.30%P/E RatioN/A3.0521.8017.80Price / SalesN/A4,155.94379.9697.74Price / CashN/A13.1938.2634.64Price / BookN/A33.726.443.98Net IncomeN/A-$90.50M$3.21B$247.73M7 Day PerformanceN/A2.16%2.88%1.81%1 Month PerformanceN/A-5.14%-8.63%-6.98%1 Year PerformanceN/A86.16%11.46%1.29% NLS Pharmaceutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NLSPWNLS PharmaceuticsN/A$0.00flatN/A-91.0%$0.00N/A0.006Short Interest ↑Negative NewsATNFW180 Life SciencesN/A$0.01+1.4%N/A-21.0%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02+1.3%N/A-80.2%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.06-43.2%N/A-2.0%$0.00$20,729.000.0040ALVOWAlvotechN/A$1.07flatN/A-65.8%$0.00$489.68M0.004Positive NewsGap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.04+1.8%N/AN/A$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.06-7.7%N/A+10.2%$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.06flatN/A-90.3%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.09-10.1%N/A-93.3%$0.00N/A0.008Positive NewsGap DownHigh Trading VolumeCELUWCelularityN/A$0.04flatN/A+17.6%$0.00$48.20M0.00220Positive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NLSPW) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NLS Pharmaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NLSPW Stock Free NLSPW Stock Alerts